Literature DB >> 1588544

Ultrasonography of diffuse liver disease. A review.

D S Biller1, B Kantrowitz, T Miyabayashi.   

Abstract

Radiographically, the liver may appear normal even if severely diseased. Ultrasonography can be an important adjunct in the evaluation of diffuse parenchymal hepatic disease. Diffuse liver disease appears ultrasonographically as a change in liver echogenicity from normal when compared with the renal cortex or spleen. Diffuse liver disease can be characterized as either hyperechoic due to fatty change, steroid hepatopathy, and cirrhosis or hypoechoic due to congestion, suppurative hepatitis, and lymphoma. Ultrasonographic diagnosis of diffuse liver disease should be substantiated by biopsy and histopathologic evaluation.

Entities:  

Mesh:

Year:  1992        PMID: 1588544     DOI: 10.1111/j.1939-1676.1992.tb03154.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  Ultrasonographic characteristics of the portal venous system of 37 healthy, unsedated, student-owned cats: A prospective study.

Authors:  Maxime Derré; Catherine Layssol-Lamour
Journal:  Can Vet J       Date:  2022-04       Impact factor: 1.075

2.  Parenchymal signal intensity in 3-T body MRI of dogs with hematopoietic neoplasia.

Authors:  Daniel A Feeney; Leslie C Sharkey; Susan M Steward; Katherine L Bahr; Michael S Henson; Daisuke Ito; Timothy D O'Brien; Carl R Jessen; Brian D Husbands; Antonella Borgatti; Jaime F Modiano
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

3.  Ultrasound imaging in an experimental model of fatty liver disease and cirrhosis in rats.

Authors:  Andréia S Lessa; Bruno D Paredes; Juliana V Dias; Adriana B Carvalho; Luiz Fernando Quintanilha; Christina M Takiya; Bernardo R Tura; Guilherme F M Rezende; Antonio C Campos de Carvalho; Célia M C Resende; Regina C S Goldenberg
Journal:  BMC Vet Res       Date:  2010-01-29       Impact factor: 2.741

4.  High-frequency ultrasound imaging to evaluate liver fibrosis progression in rats and yi guan jian herbal therapeutic effects.

Authors:  Wei Chen; Jiun-Yu Chen; Yu-Tang Tung; Hsiao-Ling Chen; Chia-Wen Kuo; Chia-Hui Chuang; Kowit-Yu Chong; Frank Chiahung Mao; Chuan-Mu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-10-23       Impact factor: 2.629

5.  Clinico-hemato-biochemical profile of dogs with liver cirrhosis.

Authors:  M A Elhiblu; K Dua; J Mohindroo; S K Mahajan; N K Sood; P S Dhaliwal
Journal:  Vet World       Date:  2015-04-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.